Upland Software Inc
NASDAQ:UPLD
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
This alert will be permanently deleted.
Upland Software Inc
Upland Software, Inc. engages in the provision of cloud-based enterprise work management software, which enables organizations to plan, manage and execute projects and work. The company is headquartered in Austin, Texas and currently employs 865 full-time employees. The company went IPO on 2014-11-06. The firm products include AccuRoute, Adestra, Altify, BlueVenn, Cimpl, ComSci, Eclipse PPM, FileBound, InGenius, Intelligent Capture, InterFAX, Kapost, Localytics, Mobile Messaging, Objectif Lune, Panviva, PostUp, PowerSteering, professional services automation (PSA), Qvidian, Rant & Rave, RightAnswers, RO Innovation, Second Street and Ultriva. The company offers its products for business operations, contact center, human resource and legal, information technology, marketing, project management and sales. Its customers operate in a range of industries, including financial services, consulting services, technology, manufacturing, media, telecommunications, government, political, non-profit, healthcare, life sciences, retail and hospitality. Its applications deliver value to the customer experience (CXM), including mobile messaging, mobile application marketing and Voice of Customer engagement (VoC).
Upland Software, Inc. engages in the provision of cloud-based enterprise work management software, which enables organizations to plan, manage and execute projects and work. The company is headquartered in Austin, Texas and currently employs 865 full-time employees. The company went IPO on 2014-11-06. The firm products include AccuRoute, Adestra, Altify, BlueVenn, Cimpl, ComSci, Eclipse PPM, FileBound, InGenius, Intelligent Capture, InterFAX, Kapost, Localytics, Mobile Messaging, Objectif Lune, Panviva, PostUp, PowerSteering, professional services automation (PSA), Qvidian, Rant & Rave, RightAnswers, RO Innovation, Second Street and Ultriva. The company offers its products for business operations, contact center, human resource and legal, information technology, marketing, project management and sales. Its customers operate in a range of industries, including financial services, consulting services, technology, manufacturing, media, telecommunications, government, political, non-profit, healthcare, life sciences, retail and hospitality. Its applications deliver value to the customer experience (CXM), including mobile messaging, mobile application marketing and Voice of Customer engagement (VoC).
Revenue Beat: Upland beat its Q3 2025 revenue guidance midpoint, despite expected declines from recent divestitures.
Profitability: Adjusted EBITDA met guidance at $16 million, with a margin of 32%, up sharply from 21% a year ago.
Growth: Core organic growth turned positive at 3% in Q3, with management targeting further acceleration to 3% in 2026 and 5% beyond.
Cash Flow & Leverage: Free cash flow was $6.7 million for the quarter; net debt leverage fell to 3.8x, with a year-end target of 3.7x.
AI Momentum: Won major new AI-driven deals with a Fortune 100 tech company ($2 million multiyear) and a global pharma company ($1 million multiyear).
Guidance Lowered: Full-year 2025 revenue and adjusted EBITDA guidance midpoints lowered by $800,000 due to weaker perpetual license and services revenue, but subscription revenue guidance unchanged.
Margin Expansion: Full-year adjusted EBITDA margin expected at 27% (up from 20% last year), with a long-term target of 32%.
